Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carrie MacEwen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|November 5, 2015
Carrie MacEwen: Champions vision and visibilityCarrie MacEwen
BMJ (Clinical Research Ed.)|November 20, 2014
What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders?Andrew Lotery, Carrie MacEwen
BMJ (Clinical Research Ed.)|June 17, 2018
Helping patients choose wiselyJack Ross, Ramai Santhirapala, Carrie MacEwen, et al.
Eye (London, England)|March 1, 2019
Failing to plan and planning to fail. Can we predict the future growth of demand on UK Eye Care Services?John Cameron Buchan, Paul Norman, Darren Shickle, et al.
BMJ (Clinical Research Ed.)|March 17, 2026
We must be more systematic about risk holding throughout doctors' careersChristopher Jm Whitty, Jeanette Dickson, Alan R Abraham, et al.
Eye (London, England)|February 10, 2018
Response to: 'Comment on: 'How to defuse a demographic time bomb: the way forward?'John C Buchan, Winfried Amoaku, Beth Barnes, et al.
BMJ (Clinical Research Ed.)|January 8, 2020
Rising to the challenge of multimorbidityChristopher J M Whitty, Carrie MacEwen, Andrew Goddard, et al.
Human Molecular Genetics|January 14, 2016
Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophyEdwin H A Allen, David G Courtney, Sarah D Atkinson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|November 5, 2015
Carrie MacEwen: Champions vision and visibilityCarrie MacEwen
BMJ (Clinical Research Ed.)|November 20, 2014
What is stopping the NHS from using bevacizumab for macular degeneration and other retinal disorders?Andrew Lotery, Carrie MacEwen
BMJ (Clinical Research Ed.)|June 17, 2018
Helping patients choose wiselyJack Ross, Ramai Santhirapala, Carrie MacEwen, et al.
Eye (London, England)|March 1, 2019
Failing to plan and planning to fail. Can we predict the future growth of demand on UK Eye Care Services?John Cameron Buchan, Paul Norman, Darren Shickle, et al.
BMJ (Clinical Research Ed.)|March 17, 2026
We must be more systematic about risk holding throughout doctors' careersChristopher Jm Whitty, Jeanette Dickson, Alan R Abraham, et al.
Eye (London, England)|February 10, 2018
Response to: 'Comment on: 'How to defuse a demographic time bomb: the way forward?'John C Buchan, Winfried Amoaku, Beth Barnes, et al.
BMJ (Clinical Research Ed.)|January 8, 2020
Rising to the challenge of multimorbidityChristopher J M Whitty, Carrie MacEwen, Andrew Goddard, et al.
Human Molecular Genetics|January 14, 2016
Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophyEdwin H A Allen, David G Courtney, Sarah D Atkinson, et al.
Pageof 1